Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios
Clinical Transplantation · 2023
DOI: 10.1111/ctr.14944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Kelsey Coffman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Tacrolimus, Diabetes Mellitus. Die Arbeit nennt 28 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes (DM) is a common comorbidity in transplant patients with known effects on gastrointestinal (GI) motility and absorption; however, DM's impact on immediate release (IR) tacrolimus to LCP‐tacrolimus (LCP) conversion ratios has not been studied. This multivariable analysis of a retrospective longitudinal cohort study included kidney transplant recipients converted from IR to LCP between 2019 and 2020. The primary outcome was IR to LCP conversion ratio based on DM status. Other outcomes included tacrolimus variability, rejection, graft loss, and death. Of the 292 patients included, 172 patients had DM and 120 did not. The IR:LCP conversion ratio was significantly higher with DM (67.5% ± 21.1% no DM vs. 79.8% ± 28.7% in DM; P < .001). In multivariable modeling, DM was the only variable significantly and independently associated with IR:LCP conversion ratios. No difference was observed in rejection rates. Graft (97.5% no DM vs. 92.4% in DM; P = .062) and patient survival (100% no DM vs. 94.8% in DM; P = .011) were lower with DM. The presence of DM significantly increased the IR:LCP conversion ratio by 13%–14%, compared to patients without DM. On multivariable analysis, DM was the only significant predictor of conversion ratios, potentially related to GI motility or absorption differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Pharmacy, Ralph H Johnson VAMC, Charleston, South Carolina, USA.
ORCID-Profile: Kelsey Coffman, Neha Patel, Shikha Patel, David Taber
Zitieren
APA
Coffman, K., Patel, N., Bartlett, F., Newman, J., Patel, S., Sprague, T., Rao, N., Andrade, E., Casey, M. J., Rohan, V., DuBay, D., & Taber, D. (2023). Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios. Clinical Transplantation. https://doi.org/10.1111/ctr.14944
Vancouver
Coffman K, Patel N, Bartlett F, Newman J, Patel S, Sprague T, et al. Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios. Clinical Transplantation. 2023. doi:10.1111/ctr.14944
BibTeX
@article{Coffman2023,
author = {Coffman, Kelsey and Patel, Neha and Bartlett, Felicia and Newman, Jessica and Patel, Shikha and Sprague, Taylor and Rao, Nikhil and Andrade, Erika and Casey, Michael J and Rohan, Vinayak and DuBay, Derek and Taber, David},
title = {Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.14944}
}
EUVIMED